Quantum Biopharma (QNTM) Profit After Tax (QoQ) (2019 - 2026)

Quantum Biopharma (QNTM) Profit After Tax (QoQ) (2019 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Quantum Biopharma 13.11 Bn 13.10 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -348.06%
Dec 31, 2025 43.10%
Sep 30, 2025 42.52%
Jun 30, 2025 -7.89%
Mar 31, 2025 -310.09%
Dec 31, 2024 45.35%
Sep 30, 2024 -22.98%
Jun 30, 2024 -63.49%
Jun 30, 2021 -232.80%
Sep 30, 2020 -378.02%
Jun 30, 2020 53.48%
Mar 31, 2020 52.91%
Dec 31, 2019 -0.58%
Sep 30, 2019 -9.58%
Jun 30, 2019 -578.87%